Skip to main content

Advertisement

Log in

Obstacles to Widening Biosample Research

  • Original Paper
  • Published:
Science and Engineering Ethics Aims and scope Submit manuscript

Abstract

Switzerland has an excellent culture of medical research and is a melting pot for medical experts with international expertise. Nevertheless, as in other countries, the resources available to medical researchers are not being fully used. Biological samples, which enable a host of medical research studies to be carried out without invasive methods involving patients, are frequently left unused or forgotten. The aim of this study is to examine the experiences of biobank stakeholders regarding the use or underuse of biosamples, in order to develop paths to optimize biosample research. Interviews were carried out with 36 biobank stakeholders in Switzerland concerning their experiences with biosample use, and the possible obstacles at each stage of the process. Interviews revealed that standard operating procedures were the most frequently cited obstacle, although these were not judged to be severe hindrances. Despite a stated desire to develop biosample research, skepticism of sharing networks and wariness of new partnerships were strong themes. Biobanking still functions as an emerging field, in which exchange practices have yet to be established at the national and international levels. Sample exchange continues to function largely based on personal contacts; while this is an inherent feature of competitive medical research, opportunities for large-scale studies may be lost due to excessive caution.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Asslaber, M., & Zatloukal, K. (2007). Biobanks: Transnational, European and global networks. Briefings in Functional Genomics & Proteomics, 6(3), 193–201. doi:10.1093/bfgp/elm023.

    Article  Google Scholar 

  • Betsou, F., Rimm, D. L., Watson, P. H., Womack, C., Hubel, A., Coleman, R. A., Horn, L., Terry, S. F., Zeps, N., Clark, B. J., Miranda, L. B., Hewitt, R. & Elliott, G. D. (2010). What are the biggest challenges and opportunities for biorepositories in the next three to five years? Biopreservation and Biobanking. doi:10.1089/bio.2010.8210.

    Google Scholar 

  • Colledge, F., & Elger, B. (2015). Getting a fair share: Attitudes and perceptions of biobank stakeholders concerning the fairness of sample sharing. Bioethics, 29(6), 424–430. doi:10.1111/bioe.12134.

    Article  Google Scholar 

  • Colledge, F., Elger, B., & Howard, H. C. (2013a). A review of the barriers to sharing in biobanking biopreservation and biobanking, 11(6), 339–346. doi:10.1089/bio.2013.0039.

    Article  Google Scholar 

  • Colledge, F. M., Elger, B. S., & Shaw, D. M. (2013b). “Conferring authorship”: Biobank stakeholders’ experiences with publication credit in collaborative research. PLoS ONE, 8(9), e76686. doi:10.1371/journal.pone.0076686.

    Article  Google Scholar 

  • Colledge, F., Persson, K., Elger, B., & Shaw, D. (2014). Sample and data sharing barriers in biobanking: Consent, committees, and compromises. Annals of Diagnostic Pathology, 18(2), 78–81. doi:10.1016/j.anndiagpath.2013.12.002.

    Article  Google Scholar 

  • Dillner, J., & Andersson, K. (2011). Biobanks collected for routine healthcare purposes: Build-up and use for epidemiologic research. Methods in Molecular Biology, 675, 113–125. doi:10.1007/978-1-59745-423-0_4.

    Article  Google Scholar 

  • Gibbons, S. M. C. (2009). Regulating biobanks: A twelve-point typological tool. Medical Law Review, 17(3), 313–346. doi:10.1093/medlaw/fwp016.

    Article  Google Scholar 

  • Hagen, H. E., & Carlstedt-Duke, J. (2004). Building global networks for human diseases: Genes and populations. Nature Medicine, 10(7), 665–667. doi:10.1038/nm0704-665.

    Article  Google Scholar 

  • Harris, J. R., Burton, P., Knoppers, B. M., Lindpaintner, K., Bledsoe, M., Brookes, A. J., Budin-Ljosne, I., Chisholm, R., Cox, D., Deschênes, M., Fortier, I., Hainaut, P., Hewitt, R., Kaye, J., Litton, J. E., Metspalu, A., Ollier, B., Palmer, L. J., Palotie, A., Pasterk, M., Perola, M., Riegman, P. H. J., van Ommen, G. J., Yuille, M. & Zatloukal, K. (2012). Toward a roadmap in global biobanking for health. European Journal of Human Genetics, 20(11), 1105–1111. doi:10.1038/ejhg.2012.96.

  • Kiehntopf, M., & Krawczak, M. (2011). Biobanking and international interoperability: Samples. Human Genetics. doi:10.1007/s00439-011-1068-8.

    Google Scholar 

  • Mehrjahresprogramm 20122016. Planungseingabe zuhanden der Bundesbehörden. (2010). Bern: Stämpfli Publikationen AG.

  • Meier-Abt, P. (2013). Die schweiz braucht mehr biobank. Digma, 13(3), 81–83.

  • Rogers, J., Carolin, T., Vaught, J., & Compton, C. (2011). Biobankonomics: A taxonomy for evaluating the economic benefits of standardized centralized human biobanking for translational research. JNCI Monographs, 2011(42), 32–38. doi:10.1093/jncimonographs/lgr010.

    Article  Google Scholar 

  • Rothmayr, C. (2009). Biobanks: Governance in comparative perspective—edited by Herbert Gottweis and Alan Petersen. Governance, 22(4), 759–761. doi:10.1111/j.1468-0491.2009.01461_6.x.

    Article  Google Scholar 

  • Shaw, D. M., Elger, B. S., & Colledge, F. (2014). What is a biobank? Differing definitions among biobank stakeholders. Clinical Genetics, 85(3), 223–227. doi:10.1111/cge.12268.

    Article  Google Scholar 

  • Vaught, J., Kelly, A., & Hewitt, R. (2009). A review of international biobanks and networks: Success factors and key benchmarks. Biopreservation and Biobanking, 7(3), 143–150. doi:10.1089/bio.2010.0003.

    Article  Google Scholar 

  • Vaught, J., Rogers, J., Carolin, T., & Compton, C. (2011). Biobankonomics: Developing a sustainable business model approach for the formation of a human tissue biobank. JNCI Monographs, 2011(42), 24–31. doi:10.1093/jncimonographs/lgr009.

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the contribution of Heidi Howard, who developed the interview guide, supervised the data collection, and assisted with the coding; David Shaw, who assisted in developing codes and data analysis; and Kirsten Persson, who also give input into coding and evolution of the project. Flora Colledge’s doctoral research was funded in part by the Käthe-Zingg-Schwichtenberg Fonds of the Swiss Academy of Medical Science.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Flora Colledge or Bernice Elger.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Colledge, F., Passweg, J. & Elger, B. Obstacles to Widening Biosample Research. Sci Eng Ethics 25, 113–128 (2019). https://doi.org/10.1007/s11948-017-9985-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11948-017-9985-0

Keywords

Navigation